Related Articles
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
TP53 upregulates α‑smooth muscle actin expression in tamoxifen‑resistant breast cancer cells
Protein kinase C-α downregulates estrogen receptor-α by suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation